{
    "itemType": "dragAndDropCloze",
    "stimulus": "A 68-year-old male with a history of chronic kidney disease (CKD) is admitted to the emergency department with complaints of generalized weakness, palpitations, and nausea. Review the patient's electronic health record and complete the following sentences.",
    "itemContext": {
        "SBAR": "14:00. S: Mr. Jones, 68-year-old male, admitted with CKD, presenting with weakness, palpitations, and nausea since this morning. B: History of CKD (Stage 4), hypertension, and type 2 diabetes. Hemodialysis three times weekly; last dialysis was two days ago. A: Alert and oriented, appearing weak. Vitals: BP 180/100 mmHg, HR 110 bpm (irregular), RR 24, Temp 37.0째C (98.6째F), SpO2 94% on room air. ECG shows peaked T waves. Potassium 7.0 mEq/L. Complaining of muscle cramps; minimal urine output. R: Notified physician, received stat orders: Continuous cardiac monitoring, sodium polystyrene sulfonate (Kayexalate) 15g PO, calcium gluconate 1g IV over 5 minutes, prepare for emergent hemodialysis. Monitor potassium hourly, restrict dietary potassium, continuous telemetry, frequent vitals, assess for fluid overload. Nephrology consult requested. Reinforce low potassium diet education post-acute phase.",
        "Labs": "Potassium: 7.0 mEq/L, Sodium: 138 mEq/L, BUN: 80 mg/dL, Creatinine: 6.0 mg/dL, Glucose: 150 mg/dL, Hemoglobin: 10.0 g/dL, Hematocrit: 30%",
        "Vitals": "BP: 180/100 mmHg, HR: 110 bpm (irregular), RR: 24, Temp: 37.0째C (98.6째F), SpO2: 94% on room air",
        "Radiology": "Chest X-ray: No acute changes",
        "MAR": "Insulin Lispro 5 units subq ac; Metoprolol 25mg PO BID; Calcium Gluconate 1g IV PRN; Sodium Polystyrene Sulfonate (Kayexalate) 15g PO PRN"
    },
    "rubric": {
        "scoringType": "0/1"
    },
    "contentArea": "Renal/Urinary",
    "cognitiveLevel": "Apply",
    "clientNeed": "Physiological Adaptation",
    "safeEffectiveCareEnvironment": "Safety and Infection Control",
    "pharmTherapy": "Potassium-Removing Agents",
    "questionStem": "Complete the sentences below by dragging the correct answer choices into the appropriate spaces. Each answer choice can only be used once.\n\nMr. Jones' elevated potassium level is primarily due to decreased renal <dragArea id='drag1'></dragArea> of potassium. An ECG showing <dragArea id='drag2'></dragArea> T waves confirms the presence of hyperkalemia. The priority nursing intervention is to monitor the patient's cardiac rhythm and administer <dragArea id='drag3'></dragArea> gluconate to stabilize the cardiac membrane.",
    "correctResponses": {
        "drag1": "excretion",
        "drag2": "peaked",
        "drag3": "calcium"
    },
    "distractorOptions": [
        "reabsorption",
        "flat",
        "calcium",
        "sodium",
        "excretion",
        "peaked"
    ],
    "rationale": {
        "drag1": "In chronic kidney disease (CKD), the kidneys' ability to excrete potassium is significantly impaired, leading to hyperkalemia. The failing kidneys cannot effectively filter and eliminate potassium from the body, causing it to accumulate in the bloodstream. This is further exacerbated by the reduced glomerular filtration rate (GFR) typical in CKD.",
        "drag2": "Peaked T waves are a classic ECG finding in hyperkalemia. The elevated potassium levels affect the repolarization of the heart, resulting in the characteristic tall and peaked T waves. As hyperkalemia worsens, other ECG changes can include widened QRS complexes, prolonged PR interval, and ultimately, a sine wave pattern, which can lead to fatal arrhythmias.",
        "drag3": "Calcium gluconate is administered to stabilize the cardiac membrane by increasing the threshold potential, thereby reducing the excitability of the heart muscle. This action protects the heart from the adverse effects of hyperkalemia, such as arrhythmias. It does not lower potassium levels but provides immediate cardiac protection while other treatments to reduce potassium are initiated.",
        "correct": "The correct answers reflect the pathophysiology of hyperkalemia in CKD and the immediate interventions required to stabilize the patient. Decreased renal excretion leads to hyperkalemia, which manifests as peaked T waves on ECG. Calcium gluconate is administered to protect the heart from the effects of hyperkalemia.",
        "clinicalPearls": [
            "Hyperkalemia is a life-threatening electrolyte imbalance, especially in patients with renal failure. Early recognition and prompt treatment are essential to prevent cardiac complications. Always correlate lab values with clinical and ECG findings.",
            "ECG changes are crucial indicators of hyperkalemia severity. Peaked T waves, widened QRS complexes, and prolonged PR intervals are common findings. Continuous cardiac monitoring is vital in patients with hyperkalemia.",
            "Calcium gluconate provides immediate cardiac protection but does not lower potassium levels. Other treatments, such as insulin and glucose, sodium polystyrene sulfonate (Kayexalate), or dialysis, are required to reduce potassium levels. Remember to address the underlying cause of hyperkalemia."
        ],
        "questionTrap": {
            "trap": "Common Pitfall",
            "howToOvercome": "Students may confuse the treatments for hyperkalemia, focusing on potassium removal (e.g., Kayexalate) rather than immediate cardiac stabilization with calcium gluconate. Prioritizing interventions based on the urgency of the situation is key. The question emphasizes the immediate need to protect the heart."
        },
        "mnemonic": {
            "title": "HINT",
            "expansion": "K-EXCRETE: Kidneys EXCRETE Potassium. ECG changes in hyperkalemia: Peaked T waves, prolonged PR interval, widened QRS complex. C-BIG-K Drop: Calcium, Bicarbonate, Insulin, Glucose, Kayexalate, Dialysis (treatments for hyperkalemia)."
        }
    },
    "references": [
        "McCance, K. L., & Huether, S. E. (2019). *Pathophysiology: The biologic basis for disease in adults and children* (8th ed.). Mosby.",
        "Urden, L. D., Stacy, K. M., & Lough, M. E. (2018). *Critical care nursing: Diagnosis and management* (9th ed.). Mosby."
    ],
    "type": "dragAndDropCloze",
    "pedagogy": {
        "bloomLevel": "apply",
        "cjmmStep": "analyzeCues",
        "nclexCategory": "Physiological Adaptation",
        "topicTags": [
            "Renal/Urinary"
        ],
        "difficulty": 4
    },
    "scoring": {
        "method": "polytomous",
        "maxPoints": 1
    },
    "id": "NCLEX-2026-MISSION-500-4-1771959759626"
}